Journal of drug targeting · 2014 · 25 citations · 28 references
PharmacyPharmaceuticsPharmacologyDrug DeliveryNanoparticle Drug DeliveryTargeted Drug DeliveryCancer NanomedicineDrug EncapsulationNanocarriers For TherapeuticsNanomaterials For Drug DeliveryNanomedicineNanoparticle FormulationsCellular Uptake EfficiencyDrug Delivery NanocarriersMultifunctional NanoparticlesNanoparticle Cellular UptakeNanoparticle CytotoxicityNanoparticlesTargeted DeliveryTumor-targeted Drug Delivery
PURPOSE: An octreotide-conjugated polyamidoamine (PAMAM) dendrimer was synthesized and employed as nanocarriers of methotrexate (MTX), for targeting to the somatostatin receptors over-expressed tumor cells. METHODS: PAMAM-PEG-octreotide (PPO) and PAMAM-PEG (PPG) were synthesized and characterized. The cellular uptake of fluorescein isothiocyanate (FITC)-labeled PPO (PPO-FITC) and PPG (PPG-FITC) were investigated. The cytotoxicity of MTX and MTX nanoparticles were conducted in the MCF-7 cells. Besides, the pharmacokinetics studies on MTX nanoparticles were carried out in rats. RESULTS: The structure of PPO was verified by NMR detection and the diameter was 11.05 ± 1.80 nm, with the amount of MTX encapsulated by PPO was 30 (molecule/molecule). MTX nanoparticles possessed significantly higher cytotoxicity against MCF-7 cells compared with free MTX, especially the PPO/MTX nanoparticles. Correspondingly, the PPO-FITC carrier had higher cellular uptake efficiency compared to PPG-FITC. In addition, pharmacokinetics studies showed that PPO/MTX nanoparticles increased mean residence time and bioavailability of MTX distinctly. DISCUSSION AND CONCLUSION: With further cellular uptake test of FITC-labeled carriers, the enhanced cytotoxicity of PPO/MTX nanoparticles was reasonable to ascribe to the specific receptor-mediated endocytosis induced by octreotide. The present study suggests that this PAMAM-PEG-octreotide nanocarrier opens a new path for treating cancer with higher efficacy.
28
George L. Ellman · Archives of Biochemistry and Biophysics · 1959 · 26.2K citations
A PEGylated dendritic nanoparticulate carrier of fluorouracil
D. Bhadra, Sulekha Bhadra, Sanjay Jain et al. · International Journal of Pharmaceutics · 2003 · 542 citations
Targeting cancer cells with biotin–dendrimer conjugates
Wenjun Yang, Yiyun Cheng, Tongwen Xu et al. · European Journal of Medicinal Chemistry · 2008 · 289 citations
Pharmacy, Cancer Biology, Oncology +14